Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase
- PMID:9652739
- DOI: 10.1038/sj.onc.1201803
Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase
Abstract
Drug resistance that occurs during cancer chemotherapy has been a major problem in controlling neoplastic progression. To study the cellular mechanisms of acquired drug resistance we developed 1,25-dihydroxyvitamin D3 (1,25D3)-resistant sublines of promyelocytic leukemia HL60 cells which have increased proliferation rates (Exp. Cell Res., 224, 312, 1996; Cancer Res., 50, 5513, 1996). We report here that the resistant sublines display varying degrees of shortening of the G1 phase as compared to the parental HL60-G cells. Protein levels of cyclins E, D1, D2 and D3 are elevated in these resistant cell lines, and cyclin D1 is especially high in 40AF cells, which has the shortest G1 length. The protein levels of cyclin-dependent kinase (Cdk)2, Cdk4 and Cdk6 are not altered in the resistant sublines. Both Cdk2 and Cdk6-associated kinase activites are increased in the resistant sublines, but not Cdk4 kinase activity. Protein levels of p27Kip1 are not consistently altered in the resistant sublines as compared to the parental HL60-G cells, but are reduced relative to HL60-G cells arrested by 96 h treatment with 1,25D3. Interestingly, the resistant cell lines constitutively express high levels of retinoblastoma protein (pRb), and pRb is highly phosphorylated, indicating that the G1 cyclin/Cdk complexes in the resistant cells are physiologically active. The results suggest that the increased activity of cyclin D/Cdk6, and perhaps cyclin E/Cdk2, lead to rapid hyperphosphorylation of pRb and consequently a shorter early G1 phase, and that in the resistant cells the increased ratio of cyclin E to p27Kip1 results in activation of Cdk2 and contributes to the abrogation of the 1,25D3-induced block to the S phase entry. Additionally, it is apparent that constitutively increased levels of pRb are compatible with increased rates of cell proliferation.
Similar articles
- Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R.Zancai P, et al.Oncogene. 1998 Oct 8;17(14):1827-36. doi: 10.1038/sj.onc.1202089.Oncogene. 1998.PMID:9778049
- Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.Said TK, Medina D.Said TK, et al.Mol Carcinog. 1998 Jun;22(2):128-43.Mol Carcinog. 1998.PMID:9655257
- Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.Sweeney KJ, Sarcevic B, Sutherland RL, Musgrove EA.Sweeney KJ, et al.Oncogene. 1997 Mar 20;14(11):1329-40. doi: 10.1038/sj.onc.1200951.Oncogene. 1997.PMID:9178893
- The cell cycle kinases.Pines J.Pines J.Semin Cancer Biol. 1994 Aug;5(4):305-13.Semin Cancer Biol. 1994.PMID:7803767Review.
- Where the cell cycle and histones meet.Ewen ME.Ewen ME.Genes Dev. 2000 Sep 15;14(18):2265-70. doi: 10.1101/gad.842100.Genes Dev. 2000.PMID:10995383Review.No abstract available.
Cited by
- Cyclin E: a potential treatment target to reverse cancer chemoresistance by regulating the cell cycle.Pang W, Li Y, Guo W, Shen H.Pang W, et al.Am J Transl Res. 2020 Sep 15;12(9):5170-5187. eCollection 2020.Am J Transl Res. 2020.PMID:33042412Free PMC article.Review.
- Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor.Garay E, Donnelly R, Wang X, Studzinski GP.Garay E, et al.J Cell Physiol. 2007 Dec;213(3):816-25. doi: 10.1002/jcp.21150.J Cell Physiol. 2007.PMID:17520689Free PMC article.
- Antiproliferative role of vitamin D and its analogs--a brief overview.Banerjee P, Chatterjee M.Banerjee P, et al.Mol Cell Biochem. 2003 Nov;253(1-2):247-54. doi: 10.1023/a:1026072118217.Mol Cell Biochem. 2003.PMID:14619976Review.
- Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?Haronikova L, Bonczek O, Zatloukalova P, Kokas-Zavadil F, Kucerikova M, Coates PJ, Fahraeus R, Vojtesek B.Haronikova L, et al.Cell Mol Biol Lett. 2021 Dec 15;26(1):53. doi: 10.1186/s11658-021-00293-6.Cell Mol Biol Lett. 2021.PMID:34911439Free PMC article.Review.
- Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance.Chen-Deutsch X, Studzinski GP.Chen-Deutsch X, et al.Cell Cycle. 2012 Apr 1;11(7):1364-73. doi: 10.4161/cc.19765. Epub 2012 Apr 1.Cell Cycle. 2012.PMID:22421156Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials